| Financial Year |
March 31 2023 |
| Monetary Funds |
975,479,905.41 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
1,177,856,392.34 |
| Advances to Suppliers |
85,838,862.88 |
| Other Receivables |
27,290,991.18 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,580,121,522.22 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
61,829,011.61 |
| Total Current Assets |
3,989,856,194.39 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
73,056,585.18 |
| Investment Properties |
17,447,705.07 |
| Fixed Assetes |
1,376,410,993.22 |
| Under-construction Projects |
486,906,720.69 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
200,230,681.96 |
| R&D expenses |
-- |
| Goodwill |
306,429,515.52 |
| Long-Term Deferred and Prepaid Expenses |
2,193,766.59 |
| Deferred Income Tax Assets |
45,063,190.62 |
| Other Non-Current Assets |
161,334,789.53 |
| Sub-Total of Non-Current Assets |
2,916,275,391.95 |
| Total Assets |
6,906,131,586.34 |
| Short-Term Loans |
706,339,946.43 |
| Trading Financial liabilities |
-- |
| Notes Payable |
269,517,094.85 |
| Accounts Payable |
861,220,938.95 |
| Accounts Received In Advance |
120,323.30 |
| Employee Compensation Payable |
185,752,031.77 |
| Taxes Payable |
61,706,256.31 |
| Interest Payable |
-- |
| Dividend Payable |
465,278.00 |
| Other payables |
94,455,320.34 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
268,141,903.59 |
| Other Current Liabilities |
1,977,439.41 |
| Sub-Total of Current Liabilities |
2,568,628,818.27 |
| Long-term Loans |
1,396,013,513.65 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
3,272,167.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
2,620,768.52 |
| Deferred Income Tax Liabilities |
6,997,258.58 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,464,476,701.60 |
| Total Liabilities |
4,033,105,519.87 |
| Paid-In Capital(Or Share Stock) |
208,923,908.00 |
| Capital Surplus |
1,073,255,605.45 |
| Surplus Reserve |
67,677,382.38 |
| LESS:Treasury Stock |
19,754,169.45 |
| Undistributed Profits |
1,234,504,077.96 |
| Minority Stockholder's Interest |
288,168,038.84 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,584,858,027.63 |
| Owner's Equity（Stockholder's Equity） |
2,873,026,066.47 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
6,906,131,586.34 |
